Quick Answer
BioScience Health Innovations, Inc. reported Shares Outstanding of 10.98 million shares for fiscal year 2025.
BioScience Health Innovations, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 10.98M | +0.0% |
| 2024 | 10.98M | -73.2% |
| 2023 | 40.90M | +648.8% |
| 2022 | 5.46M | +0.0% |
| 2022 | 5.46M | +0.0% |
| 2021 | 5.46M | +0.0% |
| 2020 | 5.46M | +95.1% |
| 2019 | 2.80M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 10.98M | -73.9% | -75.0% |
| June 30, 2025 | 43.92M | +5.6% | +0.0% |
| March 31, 2025 | 43.92M | +5.6% | +300.0% |
| December 31, 2024 | 10.98M | -73.2% | -73.9% |
| September 30, 2024 | 42.10M | +3.2% | +1.2% |
| June 30, 2024 | 41.60M | +3.2% | +0.0% |
| March 31, 2024 | 41.60M | +4.4% | +1.7% |
| December 31, 2023 | 40.90M | — | +0.3% |
- BioScience Health Innovations, Inc. showed an increase of +0.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2019–2025 period, BioScience Health Innovations, Inc.’s shares outstanding has grown by 292.1% (from 2.80 million shares to 10.98 million shares).
- The most recent figure is from BioScience Health Innovations, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: